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Abstract
Background: Advances in juvenile idiopathic arthritis (JIA) treatment is promoting free disease survival.
Cardiovascular disease (CVD) may emerge as an important cause of morbidity and mortality. Pulse wave velocity
(PWV), a surrogate marker of arterial stiffness, and telomere length (TL) are considered as potential predictors of
CVD and its outcomes. The study aim was to assess PWV, TL in a JIA population and to test its correlation. In a
cross sectional study, 24 JIA patients, 21 controls for TL and 20 controls for PWV were included. PWV was assessed
by an oscillometric device. TL was assessed by qPCR. JIA activity was accessed by JADAS-27. Smoking, diabetes,
obesity, renal impairment, hypertension, dyslipidemia and inflammatory diseases were excluded.
Findings: Between cases and controls for TL, there was significant difference in age. No differences in gender,
ethnics and bone mass index between JIA and control groups for PWV and TL. The JADAS-27 median was 8. TL
was significantly reduced in JIA (0.85 ± 0.34 vs. 1. 67 ± 1.38, P = 0.025). When age adjusted by ANCOVA, the difference
remained significant (P = 0,032). PWV was normal in all patients (5.1 ± 0.20 m/s vs. 4.98 ± 0.06 m/s, P = 0, 66). There was
no correlation between TL, PWV or JADAS-27.
Conclusion: Compared to controls, JIA with high disease activity and no CVD risk factors have shorter telomeres and
normal PWV. As far as we know, this first time this correlation is being tested in rheumatic disease and in paediatrics.
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Background
Juvenile idiopathic arthritis (JIA) has chronic inflamma-
tory activity as trademark of this condition [1]. As a re-
sult in the management and survival improvement in
JIA, an increase in cardiovascular events is expected in
this group of patients [1], as observed in other rheum-
atic diseases [2].
Patient’s surveillance in this context will have an emer-
ging role. The evaluation of subclinical arterial disease is
receiving greater attention, through different methods
pointing to assess the presence of subclinical athero-
sclerosis and arteriosclerosis [3].
The increase in arterial stiffness is considered to be
the main cause of systolic pressure elevation associated
to aging and a risk predictor for cardiovascular events
and mortality [4].
Pulse wave velocity (PWV) is seen currently as the sim-
plest, non-invasive, robust and reproducible method to as-
sess arterial stiffness, validated including in children [5].
Leukocyte telomere length (TL) is also been used to
study biologic aging and cardiovascular senescence [6].
Telomeres are the tandem repeats of TTAGGG se-
quence at the ends of chromosomes [7]. Telomeres
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undergo shortening in their length every cycle cell [8]
and are found shortened in many studies associated with
cardiovascular disease [6] and autoimmune diseases [9].
Chronic inflammatory activity, oxidative stress and in-
creased leukocyte renewal are present in autoimmune
disease in general, as in JIA, and are appointed as the
main environmental factors associated to telomere
shortening [9] and impairment in endothelial function
and vascular remodelling [10]. Therefore, the study aims
were to 1) assess PWV and TL in a JIA group of pa-
tients; 2) test its correlation.
Findings
In JIA patients, PWV is increased and TL is reduced,
findings positively related to inflammatory activity.
JIA patients according to the 1997 ILAR criteria and
controls for PWV were recruited at São Lucas Hospital,
Pontif ícia Universidade Católica do Rio Grande do Sul –
(PUCRS), Porto Alegre – Brazil. We included patients
beyond seven years old and with polyarticular rheuma-
toid factor positive and negative and oligoarticular per-
sistent and extended subtypes. Obesity, smoking,
systemic hypertension, dyslipidemia renal impairment,
diabetes mellitus and other inflammatory diseases were
excluded. For TL, controls were historical from previous
studies from the same institution. The study was ap-
proved by the local ethics committee and an informed
consent was obtained from all patients. Patients below
18 years old signed a free assent.
PWV was assessed by an oscillometric non invasive
device through brachial artery occlusion (CardioSDyna –
MAPA +). Patients followed the American Heart Associ-
ation recommended instructions [3] for standard assess-
ment of arterial stiffness. They were oriented to not use
any vasoactive drugs 12 h before the evaluation and to
avoid caffeine four hours before procedure.
For measures, patients rested in the supine position
for ten minutes in a quiet room. Patients should not
spoke during the measurement to prevent the influence
of speaking on arterial tone. Evaluations were always in
the morning to control for the diurnal variation of arter-
ial stiffness. Measurements were always made by the
same observer and two consecutive measurements were
performed.
For TL, 10 ml of peripheral blood sample was col-
lected in a matched way to the routine assessment,
not representing additional procedure. qPCR was per-
formed. Peripheral mononuclear cells were purified.
Genomic DNA was extracted by phenol/chloroform/
isoamyl alcohol [11]. The relative telomere length was
performed by calculating the ratio (T/S) of a quanti-
tative PCR product from the same sample using spe-
cific primers for telomeres and a single copy gene as
described by Cawthon [12].
Inflammatory activity was assessed by Juvenile Arthritis
Disease Activity Score with 27 joints (JADAS-27) [13].
The Mann–Whitney test was used to compare healthy
controls and JIA patients. Spearman test was used to test
correlations between telomere length and JADAS, dis-
ease duration and pulse pressure. Pearson test was used
to test correlations between telomere length, age and
PWV. For controlling of confounders, Covariance ana-
lysis (ANCOVA) was used, with logarithmic transform-
ation used on asymmetric data. P values less than 0.05
were considered significant.
Twenty-four JIA patients, twenty-one controls for TL
and 20 controls for PWV were included. Between cases
and controls for PWV, there was no significant differ-
ence in age, gender, ethnics and BMI. Between cases and
controls for TL there was significant difference in age
(15.5 ± 6.3 years vs. 11.4 ± 1.3 years, P = 0,005), no differ-
ences in gender, ethnics and BMI (Table 1). The JADAS
median was 8 [0–20], indicating moderate to high dis-
ease activity. This result was more influenced by par-
ents/patient global assessment of well-being by visual
analog scale (Spearman test r = 0.872, P = 0, 001) than
erythrocyte sedimentation rate (Spearman test r = 0.277,
P = 0, 201). Oligoarticular subtype was 65.2% and there
was no prematurity in the group (Table 1).
No patient was receiving anti-inflammatory drugs.
Disease modifying activity drugs were used in 95.7% of
the group, about 30% were in corticosteroids use and
the same proportion of patients was using biologic
drugs, only Anti-TNF (Table 1).
PWV was normal in all patients, JIA and controls. The
average PWV was 5.1 ± 0.20 m/s vs. 4.98 ± 0.06 m/s,
P = 0,66). There was no correlation between pulse
pressure and PWV (r = 0.172, P = 0. 434) and JADAS
(r = 0,283, P = 0.191). There was a minimal variation
between genders: 39.8 ± 8.68 mmhg among males and
38.8 ± 10.0 mmhg in females.
There was a significant difference in T/S ratio for
telomere length between JIA patients and controls
(0.85 ± 0.34 vs.1.67 ± 1.38, P = 0.025) (Fig. 1). When
age adjusted by ANCOVA, the difference remains
significant (p = 0, 032). There was no significant difference
between JIA subtypes, gender and no association between
T/S ratio and JADAS and disease duration. The coefficient
of variation was 11%.
TL was shortened in JIA group of patients, oligoarticu-
lar and polyarticular subtypes, with long disease dur-
ation, high to moderate disease activity and no
cardiovascular risk factors, compared to controls. There
was no difference in PWV values among these groups
and there was no correlation between TL and PWV in
this group of JIA patients.
Our findings shown no evidence of correlation be-
tween TL and PWV, variables highly influenced by
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aging, in a JIA group of patients, composed by oligoarti-
cular and polyarticular subtypes, long disease duration
and disease activity considered as moderate to high.
As far as we know, this is the first study to test the
correlations between those variables in rheumatic dis-
eases and in paediatrics.
PWV and pulse pressure values were normal in JIA
patients. In literature, we found five studies to evaluate
PWV in JIA patients using different methods and with a
high heterogeneity in subtypes selected [14–18] making
comparisons difficult. We observed that studies that did
not exclude cardiovascular risk factors had positive find-
ings for PWV [14, 16–18]. Our findings are in agree-
ment with the Vlahos et al. study, which excluded those
factors, and found no difference in PWV values by to-
nometry. We believe these findings could be pointing to
a greater role of atherosclerosis in JIA patients, but no
arteriosclerosis. More studies are necessary to clarify this
setting. We found no other studies to use oscillometry
in JIA, a method highly applicable and with good corre-
lations with other methods to assess PWV [5].
In relation to TL, Prelog et al. and Dvergstein et al.
[17, 18] tested T cells and found significant differences in
JIA compared to controls. Both authors believe there is
evidence to indicate premature immunosenescence in
JIA. Dvergstein et al. found a naive T cell compartment
with shortened telomeres and reduced proliferative cap-
acity in JIA. In the study of Prelog et al., telomeric erosion
was increased in CD4+, CD45RA+ with no correlations be-
tween age, sex, disease duration, use of methotrexate and
corticosteroids, which are in agreement to our findings. In
rheumatoid arthritis, a similar study also found no correla-
tions between disease duration, disease activity index and
therapy [9]. The authors support the idea that telomere
shortening could be associated to an intrinsic defect in
telomere maintenance or low activity of telomerase than to
disease activity or immunosuppressive therapy. What is the
meaning of telomere shortening in JIA remains a question
to be answered for more studies, different than the cross-
sectional design, which are majority in this area.
Are limitations of this study the small sample size.
The significant difference in age (15.5 ± 6.3 vs.11.4 ±
1.3 years, P = 0, 005) might have been a potential bias,
but the impact of this difference might not have been
important since both groups had any participant below
7 years old, a crucial period in physiologic telomeric ero-
sion process. The coefficient of variation was 11%, a
limitation of qPCR method.
Table 1 Demographic and clinical data in patients with JIA and control for TL and JIA and controls for PWV
JIA Controls (TL) P Controls (PWV) P
n = 24 n = 21 n = 20
Age (years) 15,5 ± 6,3 11,4 ± 1,3 0, 005a 13,8 ± 5,9 0,184a
Gender - n (%)
Male 7 (26,1) 8 (40,9) 0,460b 6 (30) 0,458b
Female 17(73,9) 13 (59,1) 14 (70)
Ethnics - n (%)
Caucasian 19 (82,6) 17(81,8) 1, 000c 16 (80) 0,640c
Black 5 (17,4) 4 (18,2) 4 (20)
Weight (Kg) 50,1 ± 17,5 42,5 ± 10,2 0, 085a 46,8 ± 13,7 0,528a
Height (m) 1,52 ± 0,17 1,47 ± 0,09 0, 162a 1,44 ± 1,09 0,473a
BMI (KG/m2) 20,7 ± 3,7 19,6 ± 2,7 0, 247a 18,2 ± 4,9 0,372a
Duration disease (years) [P25 - P75] 9 [5–19]
Subtype – n (%)
Oligoarticular 15 (65,2)
Polyarticular 8 (34,8)
Medications – n(%)
Corticoids 8 (34,8)
NSAIDS 0(0,0)
Methotrexate 12 (52,2)
Leflunomide 10 (43,5)
Anti-TNF 7 (30,4)
Uveitis – n (%) 1 (4,3)
NSAIDS Nonsteroidal anti-inflammatory drugs, Anti-TNF Anti-tumour necrosis factor alpha agent
a T-student test; b Pearson test; c Fisher test
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We believe this is an interesting in vivo model to study
the inflammatory activity influence on those variables, ex-
cluding the impact of aging and cardiovascular risk fac-
tors, as potential confounders. The exclusion of patients
below seven years old had also removed from the study
group, patients that could have their PWV values in
physiologic elevation process and their TL also in physio-
logic shortening, both phenomena associated to growing.
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